References
- WHO. Global hepatitis report, 2017. Accessed March 7th, 2021 at: http://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/
- Locarnini S, Hatzakis A, Chen DS, Lok A. Strategies to control hepatitis B: public policy, epidemiology, vaccine and drugs. J Hepatol. 2015;62:S76-86. doi: 10.1016/j.jhep.2015.01.018.
- Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global burden of disease study 2010. Lancet. 2012;380:2095-128. doi: 10.1016/S0140-6736(12)61728-0.
- Schweitzer A, Horn J, Mikolajczyc RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386:1546-55. doi: 10.1016/S0140-6736(15)61412-X.
- Coalition for global hepatitis elimination. Accessed January 26th, 2022 at: https://www.globalhep.org/country-progress/Slovenia
- Hahne JMS, Veldhuijzen IK, Wiessing L, Lim TA, Salminen M, Van de Laar M. Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening. BMC Infect Dis. 2013;13:181–226. doi: 10.1186/1471-2334-13-181.
- WHO. Combating Hepatitis B and C to reach elimination by 2030. Accessed March 7th, 2021 at: http://apps.who.int/iris/bitstream/10665/206453/1/WHO_HIV_2016.04_eng.pdf
- Cox AL, El-Sayed MH, Kao JH, Lazarus JV, Lemoine M, Lok AS, et al. Progress towards elimination goals for viral hepatitis. Nat Rev Gastroenterol Hepatol. 2020;9:533-42. doi: 10.1038/s41575-020-0332-6.
- Hutin Y, Desai S, Bulterys M. Preventing hepatitis B virus infections: milestones and targets. Accessed March 7th, 2021 at: https://www.who.int/bulletin/volumes/96/7/18-215210/en/
- WHO. Hepatitis B vaccines: WHO position paper, July 2017 – Recommendations. Vaccine. 2019;37:223-5. doi: 10.1016/j.vaccine.2017.07.046.
- WHO. Status of new vaccine introduction – worldwide, September 2016. Accessed March 7th, 2021 at: http://apps.who.int/iris/bitstream/10665/252768/1/WER9201.pdf?ua=1
- Wang S, Cohen C, Tang AS, Graham CS. Hepatitis B virus elimination in the U.S.: Time to dismantle barriers and implement solutions. Curr Hepatol Report. 2021;20:34-42. doi: https://doi.org/10.1007/s11901-020-00557-3
- Pravilnik o določitvi Programa cepljenja in zaščite z zdravili za leto 2021. Accessed January 26 th, 2022 at: https://www.nijz.si/sites/www.nijz.si/files/uploaded/pr.prog.ceplj_2021.pdf
- Official gazette of Rupublic of Slovenia. Pravilnik o cepljenju, zaščiti z zdravili in varstvu pred vnosom in razširjenjem nalezljivih bolezni. Accessed March 7th, 2021 at: https://www.uradni-list.si/1/content?id=18410
- Seme K, Komloš Fujs K, Poljak M. Screening of pregnant women for hepatitis B virus infection. Med Razgl. 2006;45(Suppl3):123-6. Slovenian.
- ECDC. Antenatal screening for HIV, hepatitis B, syphilis and rubella susceptibility in the EU/EEA – addressing the vulnerable populations. 2017. Accessed March 7th, 2021 at: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/antenatal-screening-sci-advice-2017.pdf
- Collins English Dictionary. Origin. Accessed Juanuary 27th, 2022 at: https://www.collinsdictionary.com/dictionary/english/origin
- EASL. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67:370-98. doi: 10.1016/j.jhep.2017.03.021
- Grasselli Kmet N, Poljak M, Rajter M, Selič T, Baklan Z, Pal E et al. Vaccination in the Yugoslav National Army: a significant risk factor for acquiring chronic hepatitis B virus infection during army service in former Yugoslavia. J Arch Mil Med 2020;8(4):e111950. Doi: 10.5812/jamm.111950.
- ECDC. Systematic review on hepatitis B and C prevalence in the EU/ EEA. 2016. Accessed March 7th, 2021 at: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/systematic-review-hepatitis-B-C-prevalence.pdf
- Van Damme P, Leuridan E, Hendrickx G, Vorsters A, Theeten H, Leino T, et al. Should Europe have universal hepatitis B vaccination programme? BMJ. 2013;346:f4057. doi:10.1136/bmj.f4057.
- WHO. Prevention of mother-to-child transmission of hepatitis B virus: guidelines onantiviral prophylaxis in pregnancy. 2020. Accessed March 7th, 2021 at: https://apps.who.int/iris/bitstream/handle/10665/333391/9789240002708-eng.pdf?sequence=1&isAllowed=y
- Kojouharova M, Kurchatova A. Bulgaria: Impact of the universal newborn HBV vaccination programme: 20 years after. Viral hepatitis prevention board meeting. Milan, Italy, November 17-18, 2011. Accessed March 7th, 2021 at: http://www.vhpb.org/files/html/Meetings_and_publications/Presentations/MILS45.pdf
- Ni YH, Huang LM, Chang MH, Yen CJ, Lu CY, You SL, et al. Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies. Gastroenterology. 2007;132:1287–93. doi: 10.1053/j.gastro.2007.02.055.
- Liu J, Liang W, Jing W, Liu M. Countdown to 2030: eliminating hepatitis B disease, China. 2019. Accessed March 7th, 2021 at: https://www.who.int/bulletin/volumes/97/3/18-219469/en/
- Chen DS. Hepatitis B vaccination: The key toward elimination and eradication of hepatitis B. J Hepatol. 2009;50:805-16. doi: 10.1016/j.jhep.2009.01.002.
- Hadziyannis SJ. Natural history of chronic hepatitis B in Euro-Mediterranean and African countries. J Hepatol. 2011;55:183-91. doi: 10.1016/j.jhep.2010.12.030.
- Wu JF, Chang MH. Natural history of chronic hepatitis B virus infection from infancy to adult life – the mechanism of inflammation triggering and long-term impacts. J Biomed Sci. 2015;22:92-116. doi: 10.1186/s12929-015-0199-y.